Back
Catalyst Pharmaceuticals Stock Predictions
Sponsored
CPRX
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
$21.62
Seasonality Move:
14.26%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Catalyst Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 43.7% based on the past 18 years of stock performance.
-
Catalyst Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Catalyst Pharmaceuticals Stock Undervalued?The current Catalyst Pharmaceuticals [CPRX] share price is $21.62. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 43.7% based on the past 18 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals overpriced?
-
Catalyst Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
24.27
52-Week Low:
13.12
Prediction Charts
Market Cap:
2.6B
Price in USD:
21.62
Volume:
247.3K
Beta:
1.09
Technical Analysis
SMA50:
21.77
SMA100:
20.73
SMA200:
18.31
52-Wk Change:
30.4%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?Yes, Catalyst Pharmaceuticals is a publicly traded company.
-
What is the Catalyst Pharmaceuticals stock quote today?The Catalyst Pharmaceuticals stock price is 21.62 USD today.
-
How to buy Catalyst Pharmaceuticals stock online?You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 21.74 | 21.70 | 21.92 | 21.50 |
Dec-6 | 21.83 | 22.02 | 22.08 | 21.79 |
Dec-9 | 22.12 | 21.74 | 22.35 | 21.71 |
Dec-10 | 21.82 | 22.11 | 22.14 | 21.70 |
Dec-11 | 22.11 | 21.97 | 22.14 | 21.58 |
Dec-12 | 21.86 | 21.34 | 22.03 | 21.31 |
Dec-13 | 21.27 | 21.38 | 21.42 | 20.93 |
Dec-16 | 21.43 | 21.65 | 22.04 | 21.33 |
Dec-17 | 21.64 | 22.07 | 22.49 | 21.64 |
Dec-18 | 22.08 | 21.35 | 22.67 | 21.17 |
Dec-19 | 21.62 | 21.46 | 21.75 | 21.11 |
Dec-20 | 21.27 | 21.27 | 21.41 | 21.01 |
Dec-23 | 21.21 | 21.60 | 21.63 | 21.21 |
Dec-24 | 21.54 | 21.62 | 21.64 | 21.35 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.